Medical Institutions (TSE: DR) Third Quarter 2022 Results
Main financial results
- Revenue: $102.2 million (up 6.0% compared to Q3 2021).
- Net loss: $10.5 million (loss increased by 195% compared to Q3 2021).
- Loss of $0.35 per share (further deteriorated from the loss of $0.11 in 3Q 2021).
All figures shown in the table above are for the 12 month period (TTM)
EPS medical facilities fall short of expectations
Revenue is in line with analysts’ estimates. Earnings per share (EPS) missed analysts’ estimates.
Going forward, revenues are expected to grow by an average of 1.6% per year over the next 3 years, compared to a projected growth of 4.7% for the healthcare sector in Canada.
Performance of the Canadian health industry.
Shares of the company are down 25% from a week ago.
You should find out about the 2 warning signs we spotted medical facilities (including 1 that is potentially serious).
Valuation is complex, but we help make it simple.
Find out if Medical institutions is potentially overvalued or undervalued by viewing our full analysis, which includes fair value estimates, risks and warnings, dividends, insider trading and financial health.
See the free analysis
Feedback on this article? Concerned about content? Get in touch with us directly. You can also email the editorial team (at) Simplywallst.com.
This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.